These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11689556)

  • 1. Mechanistic studies with potent and selective inducible nitric-oxide synthase dimerization inhibitors.
    Blasko E; Glaser CB; Devlin JJ; Xia W; Feldman RI; Polokoff MA; Phillips GB; Whitlow M; Auld DS; McMillan K; Ghosh S; Stuehr DJ; Parkinson JF
    J Biol Chem; 2002 Jan; 277(1):295-302. PubMed ID: 11689556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of inducible nitric-oxide synthase dimerization inhibition by novel pyrimidine imidazoles.
    Nagpal L; Haque MM; Saha A; Mukherjee N; Ghosh A; Ranu BC; Stuehr DJ; Panda K
    J Biol Chem; 2013 Jul; 288(27):19685-97. PubMed ID: 23696643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry.
    McMillan K; Adler M; Auld DS; Baldwin JJ; Blasko E; Browne LJ; Chelsky D; Davey D; Dolle RE; Eagen KA; Erickson S; Feldman RI; Glaser CB; Mallari C; Morrissey MM; Ohlmeyer MH; Pan G; Parkinson JF; Phillips GB; Polokoff MA; Sigal NH; Vergona R; Whitlow M; Young TA; Devlin JJ
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1506-11. PubMed ID: 10677491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of nitric oxide synthase dimer assembly by a heme-NO-dependent mechanism.
    Chen Y; Panda K; Stuehr DJ
    Biochemistry; 2002 Apr; 41(14):4618-25. PubMed ID: 11926824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal imidazoles block assembly of inducible NO synthase into an active dimer.
    Sennequier N; Wolan D; Stuehr DJ
    J Biol Chem; 1999 Jan; 274(2):930-8. PubMed ID: 9873034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KLYP956 is a non-imidazole-based orally active inhibitor of nitric-oxide synthase dimerization.
    Symons KT; Massari ME; Nguyen PM; Lee TT; Roppe J; Bonnefous C; Payne JE; Smith ND; Noble SA; Sablad M; Rozenkrants N; Zhang Y; Rao TS; Shiau AK; Hassig CA
    Mol Pharmacol; 2009 Jul; 76(1):153-62. PubMed ID: 19364813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BYK191023 (2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3h-imidazo[4,5-b]pyridine) is an NADPH- and time-dependent irreversible inhibitor of inducible nitric-oxide synthase.
    Tiso M; Strub A; Hesslinger C; Kenney CT; Boer R; Stuehr DJ
    Mol Pharmacol; 2008 Apr; 73(4):1244-53. PubMed ID: 18178668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes.
    Boer R; Ulrich WR; Klein T; Mirau B; Haas S; Baur I
    Mol Pharmacol; 2000 Nov; 58(5):1026-34. PubMed ID: 11040050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active-site structure analysis of recombinant human inducible nitric oxide synthase using imidazole.
    Chabin RM; McCauley E; Calaycay JR; Kelly TM; MacNaul KL; Wolfe GC; Hutchinson NI; Madhusudanaraju S; Schmidt JA; Kozarich JW; Wong KK
    Biochemistry; 1996 Jul; 35(29):9567-75. PubMed ID: 8755738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of human inducible nitric oxide synthase by S-alkyl-L-isothiocitrulline-containing dipeptides.
    Park JM; Higuchi T; Kikuchi K; Urano Y; Hori H; Nishino T; Aoki J; Inoue K; Nagano T
    Br J Pharmacol; 2001 Apr; 132(8):1876-82. PubMed ID: 11309260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular assembly of inducible NO synthase is limited by nitric oxide-mediated changes in heme insertion and availability.
    Albakri QA; Stuehr DJ
    J Biol Chem; 1996 Mar; 271(10):5414-21. PubMed ID: 8621396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects.
    Handy RL; Harb HL; Wallace P; Gaffen Z; Whitehead KJ; Moore PK
    Br J Pharmacol; 1996 Sep; 119(2):423-31. PubMed ID: 8886430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
    Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ
    Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase.
    Strub A; Ulrich WR; Hesslinger C; Eltze M; Fuchss T; Strassner J; Strand S; Lehner MD; Boer R
    Mol Pharmacol; 2006 Jan; 69(1):328-37. PubMed ID: 16223957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of inactivation of inducible nitric oxide synthase by amidines. Irreversible enzyme inactivation without inactivator modification.
    Zhu Y; Nikolic D; Van Breemen RB; Silverman RB
    J Am Chem Soc; 2005 Jan; 127(3):858-68. PubMed ID: 15656623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and activity of 2-imidazol-1-ylpyrimidine derived inducible nitric oxide synthase dimerization inhibitors.
    Davey DD; Adler M; Arnaiz D; Eagen K; Erickson S; Guilford W; Kenrick M; Morrissey MM; Ohlmeyer M; Pan G; Paradkar VM; Parkinson J; Polokoff M; Saionz K; Santos C; Subramanyam B; Vergona R; Wei RG; Whitlow M; Ye B; Zhao ZS; Devlin JJ; Phillips G
    J Med Chem; 2007 Mar; 50(6):1146-57. PubMed ID: 17315988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative functioning of dihydro- and tetrahydropterins in supporting electron transfer, catalysis, and subunit dimerization in inducible nitric oxide synthase.
    Presta A; Siddhanta U; Wu C; Sennequier N; Huang L; Abu-Soud HM; Erzurum S; Stuehr DJ
    Biochemistry; 1998 Jan; 37(1):298-310. PubMed ID: 9425051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of neuronal nitric oxide synthase by N-phenacyl imidazoles.
    Sorrenti V; Di Giacomo C; Salerno L; Siracusa MA; Guerrera F; Vanella A
    Nitric Oxide; 2001 Feb; 5(1):32-8. PubMed ID: 11178934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactions catalyzed by the heme domain of inducible nitric oxide synthase: evidence for the involvement of tetrahydrobiopterin in electron transfer.
    Hurshman AR; Marletta MA
    Biochemistry; 2002 Mar; 41(10):3439-56. PubMed ID: 11876653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.
    Southan GJ; Zingarelli B; O'Connor M; Salzman AL; Szabó C
    Br J Pharmacol; 1996 Feb; 117(4):619-32. PubMed ID: 8646406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.